when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

CAR-T · news · pharmadog

← back to CAR-T

News · CAR-T

57 stories

Jun 1, 26#ASCO26: Kelonia Therapeutics delivers an impressive in vivo CAR-T updateendpoints

May 28, 26#ASCO26: After leaving Legend, Frank Fan is ready to showcase his next projectendpoints

May 20, 26STAT+: 23andMe offers to connect users’ DNA data with medical recordsstat

May 15, 26STAT+: A political contest in the U.K. could shake up drug pricingstat

May 14, 26Makary’s departure and Cassidy’s tenuous Senate seatstat

May 14, 26#ASGCT26 dispatch: In vivo CAR-T is everywhereendpoints

May 14, 26STAT+: CDC plans to transfer monkeys to nonprofit’s sanctuary as it seeks to reduce animal testingstat

May 14, 26STAT+: The hunt for FDA’s next leaderstat

May 14, 26Create Medicines raises $122M to bolster in vivo CAR-T therapiesbiopharma dive

May 14, 26Degron, CREATE, TenNor raise capital; Cabaletta posts CAR-T dataendpoints

May 14, 26STAT+: BeOne wins FDA approval in lymphoma racestat

May 14, 26STAT+: Why big digital health players are missing from Medicare’s chronic care experimentstat

May 14, 26STAT+: Biogen’s tau-targeting Alzheimer’s drug posts mixed results in mid-stage studystat

May 14, 26STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 millionstat

May 14, 26STAT+: Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submissionstat

May 11, 26Precision in motion: Decoding the critical operations behind the logistics of next-generation cell and gene therapiesbiopharma dive

May 7, 26Seaport’s IPO adventure, obesity pill battles, and Makary’s troublesstat

May 7, 26Track the Lung Cancer Abstracts That are Gaining Attention at ASCO 2026onclive

May 7, 26STAT+: Color me skeptical: Drinking gold is not an ALS curestat

May 1, 26J&J axes pair of CAR-T therapies for lymphoma, citing evolving marketendpoints

Apr 30, 26STAT+: Hair-raising trial results, and Servier’s M&A wishliststat

Apr 30, 26STAT+: What does Akeso’s primo plenary spot say about its survival data?stat

Apr 25, 26Sanofi’s immunology reckoning; Lilly acquires in vivo CAR-T biotech; RevMed’s ‘Herceptin moment’; and moreendpoints

Apr 24, 26STAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2Bstat

Apr 23, 26A CAR-T biotech’s dramatic turnaround, and drugmakers’ tactics to drive more scriptsstat

Dec 23, 25Fierce Biotech Layoff Tracker 2026: Kolon cuts workforce after ph. 3 fail; Sanofi sheds 229 staffersfiercebiotech

Dec 22, 25Fierce Biotech Fundraising Tracker '26: Abcuro secures $66M; InduPro assembles $77Mfiercebiotech

← prevpage 2 of 2next →